Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.31 |
| ▸ | SQOR | Q9Y6N5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21410208 | 0.87 | KDM4E (0.31) | KDM4EALDH1A1GLAGAAHPGD | |
| SCHEMBL21938187 | 0.87 | KDM4E (0.31) | KDM4EALDH1A1GLAGAAHPGD | |
| SCHEMBL21937265 | 0.82 | KDM4E (0.31) | KDM4EALDH1A1GLAGAAHPGD | |
| SCHEMBL7076699 | 0.80 | KIF11 (0.31) | KDM4EALDH1A1GLAGAAHPGD | |
| SCHEMBL26223293 | 0.75 | — | — | |
| SCHEMBL16122306 | 0.74 | KDM4E (0.34) | KDM4EALDH1A1GLAGAAHPGD | |
| SCHEMBL26223333 | 0.74 | CXCR2 (0.32) | SQOR | |
| SCHEMBL57543 | 0.73 | TRPV4 (0.41) | ALDH1A1HPGDTRPV4 | |
| SCHEMBL16122043 | 0.72 | AR (0.38) | TRPV4SQOR | |
| SCHEMBL28669569 | 0.72 | TRPV4 (0.30) | TRPV4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230255105-A1 | ORGANIC COMPOUNDS WITH DELAYED FLUORESCENCE EMISSION AND CIRCULARLY POLARISED LUMINESCENCE AND USE THEREOF | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2023-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230255105-A1 | ORGANIC COMPOUNDS WITH DELAYED FLUORESCENCE EMISSION AND CIRCULARLY POLARISED LUMINESCENCE AND USE THEREOF | TEAD2, TEAD4, AAAS | KDM4E 2584/4885ALDH1A1 503/4885GLA 157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.